Market Overview:
The global obesity treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of obesity, rising awareness about the benefits of obesity treatment, and technological advancements in the field of obesity treatment. The surgical & implant devices segment is expected to dominate the global obesity treatment market in terms of revenue share during the forecast period. This segment is projected to grow at a CAGR of 8% from 2018 to 2030. The high growth rate for this segment can be attributed to technological advancements in surgical & implant devices and increasing demand for minimally invasive procedures for treating obesity. In terms of application, adults are expected to account for majority share (81%)of the global Obesity Treatment Market by 2030 owingto high prevalence ratesof adultobesity across regions worldwide .
Product Definition:
The definition of obesity treatment is the use of treatments, interventions, or methods to help a person lose weight and keep it off. Obesity is a serious health condition that can lead to type 2 diabetes, heart disease, stroke, cancer, and other health problems. Treatment for obesity may include changes in diet and physical activity habits; medications such as orlistat (Xenical) or sibutramine (Meridia); surgery; and counseling.
Surgical & Implant Devices:
Surgical & implant devices, it's usage.
*** The global surgical & implant devices, it's usage and growth factor in the obesity treatment market size was valued at USD 4.2 billion in 2016. It is expected to grow at a CAGR of XX% over the forecast period on account of increasing prevalence of obese population coupled with rising healthcare expenditure across the globe.
Medication Therapy:
Medication therapy is a treatment plan used for obesity. It includes using one or more anti-obesity drugs along with behavioral therapy. The drug or drugs taken should be prescribed by a healthcare professional and must be effective in reducing weight.
Factors that propel the growth of this market include growing prevalence of obesity, increasing awareness about available treatment options, technological advancements in medication & devices used for treating this condition,.
Application Insights:
The adults segment held the largest share of over 70.0% in 2017. The growing geriatric population, especially in countries such as the U.S., China, Germany and Russia is expected to be one of the key drivers for this application segment during the forecast period. For instance, as per a study conducted by Longeveron LLC in 2016, it was found that around 60 million Americans aged 65 years or above were obese; out of which 37% were considered obese Class III or higher (with a Body Mass Index (BMI) greater than 35).
Dietary management is expected to be one of the fastest-growing segments owing to increasing awareness about calorie intake and expenditure among consumers across various regions including North America and Europe.
Regional Analysis:
North America dominated the global obesity treatment market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of obesity and related health issues, rising adoption of bariatric surgeries, growing awareness about weight loss surgery procedures and presence of well-established healthcare facilities in this region. Moreover, favorable reimbursement policies for bariatric surgical procedures are also anticipated to boost revenue growth during the forecast period.
Asia Pacific is estimated to be fastest-growing regional market over the forecast years owing to high prevalence of obesity coupled with rising disposable income levels in developing economies such as India & China & Indonesia & Malaysia etc., which will lead towards an increase in demand for various treatment options available for obese patients including diet plans and medication therapies. In addition, supportive government initiatives aimed at reducing population’s unhealthy eating habits by providing subsidies on fruits and vegetables may further boost revenue growth during the projected time frame.
Growth Factors:
- Increasing awareness about obesity and its health risks
- Rising prevalence of obesity in both developed and developing countries
- Growing demand for weight loss treatments and surgeries
- Availability of new, more effective weight loss drugs and therapies
- Increasing focus on preventive healthcare
Scope Of The Report
Report Attributes
Report Details
Report Title
Obesity Treatment Market Research Report
By Type
Surgical & Implant Devices, Medication Therapy, Dietary, Other
By Application
Children, Adults
By Companies
NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), USGI Medical (U.S.), Olympus Corporation (Japan), Brunswick Corporation (U.S.), Technogym SpA (Italy)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Obesity Treatment Market Report Segments:
The global Obesity Treatment market is segmented on the basis of:
Types
Surgical & Implant Devices, Medication Therapy, Dietary, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NutriSystem, Inc. (U.S.)
- Kellogg Company (U.S.)
- Ethicon, Inc. (U.S.)
- Medtronic (U.S.)
- F. Hoffmann-La Roche (Switzerland)
- Atkins Nutritionals, Inc. (U.S.)
- Herbalife Ltd. (U.S.)
- Covidien plc (U.S.)
- Apollo Endosurgery (U.S.)
- Amer Sports (Finland)
- Johnson Health Technology, Ltd. (Taiwan)
- Cybex International (U.S.)
- USGI Medical (U.S.)
- Olympus Corporation (Japan)
- Brunswick Corporation (U.S.)
- Technogym SpA (Italy)
Highlights of The Obesity Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgical & Implant Devices
- Medication Therapy
- Dietary
- Other
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Obesity Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Obesity treatment is a combination of diet and exercise to help people lose weight.
Some of the major players in the obesity treatment market are NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), USGI Medical (U.S.), Olympus Corporation (Japan), Brunswick Corporation (U.S.), Technogym SpA (Italy).
The obesity treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Obesity Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Obesity Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Obesity Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Obesity Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Obesity Treatment Market Size & Forecast, 2018-2028
4.5.1 Obesity Treatment Market Size and Y-o-Y Growth
4.5.2 Obesity Treatment Market Absolute $ Opportunity
Chapter 5 Global Obesity Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Obesity Treatment Market Size Forecast by Type
5.2.1 Surgical & Implant Devices
5.2.2 Medication Therapy
5.2.3 Dietary
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Obesity Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Obesity Treatment Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Obesity Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Obesity Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Obesity Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Obesity Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Obesity Treatment Market Size Forecast by Type
9.6.1 Surgical & Implant Devices
9.6.2 Medication Therapy
9.6.3 Dietary
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Obesity Treatment Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Obesity Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Obesity Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Obesity Treatment Market Size Forecast by Type
10.6.1 Surgical & Implant Devices
10.6.2 Medication Therapy
10.6.3 Dietary
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Obesity Treatment Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Obesity Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Obesity Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Obesity Treatment Market Size Forecast by Type
11.6.1 Surgical & Implant Devices
11.6.2 Medication Therapy
11.6.3 Dietary
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Obesity Treatment Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Obesity Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Obesity Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Obesity Treatment Market Size Forecast by Type
12.6.1 Surgical & Implant Devices
12.6.2 Medication Therapy
12.6.3 Dietary
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Obesity Treatment Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Obesity Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Obesity Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Obesity Treatment Market Size Forecast by Type
13.6.1 Surgical & Implant Devices
13.6.2 Medication Therapy
13.6.3 Dietary
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Obesity Treatment Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Obesity Treatment Market: Competitive Dashboard
14.2 Global Obesity Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 NutriSystem, Inc. (U.S.)
14.3.2 Kellogg Company (U.S.)
14.3.3 Ethicon, Inc. (U.S.)
14.3.4 Medtronic (U.S.)
14.3.5 F. Hoffmann-La Roche (Switzerland)
14.3.6 Atkins Nutritionals, Inc. (U.S.)
14.3.7 Herbalife Ltd. (U.S.)
14.3.8 Covidien plc (U.S.)
14.3.9 Apollo Endosurgery (U.S.)
14.3.10 Amer Sports (Finland)
14.3.11 Johnson Health Technology, Ltd. (Taiwan)
14.3.12 Cybex International (U.S.)
14.3.13 USGI Medical (U.S.)
14.3.14 Olympus Corporation (Japan)
14.3.15 Brunswick Corporation (U.S.)
14.3.16 Technogym SpA (Italy)
